Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Plus Therapeutics (PSTV) Return on Assets (2016 - 2025)

Plus Therapeutics (PSTV) has disclosed Return on Assets for 15 consecutive years, with 0.9% as the latest value for Q4 2025.

  • Quarterly Return on Assets rose 125.0% to 0.9% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.9% through Dec 2025, up 125.0% year-over-year, with the annual reading at 1.37% for FY2025, 25.0% up from the prior year.
  • Return on Assets for Q4 2025 was 0.9% at Plus Therapeutics, up from 0.96% in the prior quarter.
  • The five-year high for Return on Assets was 0.54% in Q1 2022, with the low at 2.15% in Q4 2024.
  • Average Return on Assets over 5 years is 1.08%, with a median of 1.06% recorded in 2023.
  • The sharpest move saw Return on Assets tumbled -107bps in 2024, then soared 125bps in 2025.
  • Over 5 years, Return on Assets stood at 0.56% in 2021, then plummeted by -53bps to 0.86% in 2022, then decreased by -25bps to 1.08% in 2023, then tumbled by -99bps to 2.15% in 2024, then skyrocketed by 58bps to 0.9% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.9%, 0.96%, and 1.19% for Q4 2025, Q3 2025, and Q2 2025 respectively.